Therefore, although the exact mechanism of IL-33's promotion of CRC development is still unknown, its pro-tumor function in the colorectal mucosa is likely due to a combination of several mechanisms (see Figure 1). This evidence concerns the gene IL33 and colorectal carcinoma.